Cancer Type |
EGFR expression |
HER-2 expression |
Approved Targeted Therapy |
Breast Cancer |
Yes |
Yes |
lapatinib, trastuzumab, pertuzumab, T-DM1 |
Colorectal Cancer |
Yes |
Yes |
cetuximab, panitumumab |
Gastric Cancer (GEJ) |
No |
Yes |
Trastuzumab |
HNSCC |
Yes |
No |
Cetuximab |
NSCLC |
Yes |
No |
afatinib, erlotinib, gefitinib |
Pancreatic Cancer |
Yes |
Yes |
Erlotinib |
|